CA2167538A1 - Stabilisation de proteines aerosols - Google Patents

Stabilisation de proteines aerosols

Info

Publication number
CA2167538A1
CA2167538A1 CA 2167538 CA2167538A CA2167538A1 CA 2167538 A1 CA2167538 A1 CA 2167538A1 CA 2167538 CA2167538 CA 2167538 CA 2167538 A CA2167538 A CA 2167538A CA 2167538 A1 CA2167538 A1 CA 2167538A1
Authority
CA
Canada
Prior art keywords
protein
aqueous solution
peg
aerosolized
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2167538
Other languages
English (en)
Inventor
Tsutomu Arakawa
Ralph W. Niven
Steven J. Prestrelski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2167538A1 publication Critical patent/CA2167538A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Colloid Chemistry (AREA)

Abstract

Procédé de protection de protéines contre la dégradation due à la pulvérisation sous forme d'aérosol et la perte de leur activité protéique. On stabilise les protéines comprises dans l'aérosol en ajoutant à la solution aqueuse, avant sa pulvérisation, un composé polaire organique hydrosoluble, par exemple le polyéthylène-glycol, ou un tensioactif. On a également prévu une solution aqueuse de protéines stabilisées renfermant un composé polaire organique ou un tensioactif, ainsi qu'un système de pulvérisation sous forme d'aérosol de la solution aqueuse renfermant les protéines stabilisées.
CA 2167538 1993-07-19 1994-07-19 Stabilisation de proteines aerosols Abandoned CA2167538A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9384093A 1993-07-19 1993-07-19
US08/093,840 1993-07-19

Publications (1)

Publication Number Publication Date
CA2167538A1 true CA2167538A1 (fr) 1995-02-02

Family

ID=22241106

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2167538 Abandoned CA2167538A1 (fr) 1993-07-19 1994-07-19 Stabilisation de proteines aerosols

Country Status (8)

Country Link
EP (1) EP0710102A1 (fr)
JP (1) JPH09501418A (fr)
AU (1) AU691514B2 (fr)
CA (1) CA2167538A1 (fr)
FI (1) FI960253A (fr)
NO (1) NO960217L (fr)
NZ (1) NZ271181A (fr)
WO (1) WO1995003034A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
SK11142002A3 (sk) * 1999-12-30 2004-09-08 Chiron Corporation Liečivo na podávanie interleukínu-2 a stabilizovaný lyofilizovaný alebo sprejovo sušený farmaceutický prostriedok s obsahom interleukínu-2
DE60103940T2 (de) 2000-02-29 2005-07-28 Pfizer Products Inc., Groton Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
NZ548578A (en) 2001-02-02 2008-03-28 Ortho Mcneil Pharm Inc Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
US20030072717A1 (en) 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
ES2268044T3 (es) * 2001-05-21 2007-03-16 Injet Digital Aerosols Limited Composiciones para la administracion de proteinas por la via pulmonar.
JP2004087560A (ja) 2002-08-23 2004-03-18 Sansha Electric Mfg Co Ltd 電源装置
TW200938222A (en) * 2007-12-13 2009-09-16 Glaxo Group Ltd Compositions for pulmonary delivery
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (fr) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adaptateur, dispositif d'inhalation et pulvérisateur
WO2011064163A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
BR112014002593B1 (pt) 2011-08-02 2022-11-29 Alfasigma S.p.A Composição farmacêutica de avidina oxidada apropriada para inalação e kits relacionados
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3030298B1 (fr) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nébuliseur
UA121114C2 (uk) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Небулайзер, індикаторний пристрій і контейнер
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций

Also Published As

Publication number Publication date
FI960253A (fi) 1996-03-18
NZ271181A (en) 1998-06-26
NO960217L (no) 1996-03-18
AU7473294A (en) 1995-02-20
EP0710102A1 (fr) 1996-05-08
JPH09501418A (ja) 1997-02-10
WO1995003034A1 (fr) 1995-02-02
AU691514B2 (en) 1998-05-21
FI960253A0 (fi) 1996-01-18
NO960217D0 (no) 1996-01-18

Similar Documents

Publication Publication Date Title
AU691514B2 (en) Stabilization of aerosolized proteins
KR100291620B1 (ko) 부갑상선호르몬의활성단편의폐를통한전달방법
JP2747073B2 (ja) ヒト成長ホルモン製剤
CA1222948A (fr) Stimulation de l'absorption intranasale de la calcitonine dans les preparations contenant des surfactants
JP2656944B2 (ja) タンパク質性治療剤のエアロゾール化
AU2002255541B2 (en) Modulated release particles for aerosol delivery
JPH05963A (ja) ポリペプチド類組成物
CA2396781A1 (fr) Procede d'administration d'une formulation aerosol medicale
JPH0768149B2 (ja) 鼻腔内投与用調製剤およびその製法
SA95160483B1 (ar) صيغ رذاذية aerosol formuation من البيبتيدات peptides والبروتينات proteins
JP2774379B2 (ja) 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途
AU2002255541A1 (en) Modulated release particles for aerosol delivery
JPH09509927A (ja) 医薬として許容されるｄｎアーゼ配合物
AU2002306462B2 (en) Modulated release particles for aerosol delivery
AU2002306462A1 (en) Modulated release particles for aerosol delivery
US20010055610A1 (en) Medicament administration system
CA2305256C (fr) Suspensions de mometasone furoate pour la nebulisation
US6124257A (en) Method of treatment
EP1455764B1 (fr) Compositions medicinales en aerosol contenant un excipient d'amide et/ou d'ester
CA2470520A1 (fr) Compositions aerosols pharmaceutiques comportant un excipient au polyethylene-glycol fonctionnalise
WO1982003011A1 (fr) Agent de traitement des maladies des organes respiratoires
AU6189099A (en) Insulin preparations for pulmonary delivery containing menthol
Jalalipour et al. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents
EP2407176B1 (fr) Agent d'amélioration pour la bronchopneumopathie chronique obstructive
JPH05500229A (ja) 固体ポリペプチド微粒子のエアロゾル製剤とその製造方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead